Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.
Dr. Serdar Turhal is a highly experienced oncologist specializing in medical oncology and chemotherapy for breast cancer at Anadolu Medical Center. He is a member of many international oncology associations and has authored numerous articles in international publications. He specializes in prognostic factors and the therapy of malignant gastrointestinal neoplasms. To receive a consultation from Dr. Turhal, please submit a request on Bookimed.
20 top ranked Chemotherapy doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Chemotherapy doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Chemotherapy doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on Chemotherapy varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Chemotherapy if you have any difficulties with a choice. Bookimed services are free for patients ♥
Prof. Dr. Ümmügül Üyetürk completed her undergraduate and graduate education at Uludağ University Faculty of Medicine between 1988-1994. She specialized in Internal Medicine at Istanbul Training and Research Hospital from 1998 to 2003. Between 2008-2011, she received her subspecialty training in Medical Oncology at Ankara Oncology Training and Research Hospital.
After serving as the deputy chief physician at Suluova State Hospital, she established the Internal Medicine Department and Medical Oncology Science Branch at Bolu Abant İzzet Baysal University between 2011-2020, where she served as the head of the science branch. During this time, she educated resident doctors and students. Üyetürk, who received the title of Associate Professor in 2014, spent 6 months in Canada/Toronto in 2019. In 2020, she was awarded the title of Professor at Abant İzzet Baysal University.
Üyetürk has published over 60 articles in international peer-reviewed journals and has more than 20 scientific works published in national peer-reviewed journals. She also has over 100 presentations that have been delivered at international and national scientific meetings and published in proceedings books. In addition to her membership in the European Society for Medical Oncology, she has memberships in medical oncology associations within the country. She has received more than 10 awards given to her at universities and congresses.
Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.
Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."
In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.
Prof. Sadi Kerem Okutur is a Turkish medical oncologist with over 20 years of experience. He is currently working at Memorial Bahçelievler Hospital, and has held various positions in the past. He has a degree in general medicine, and a residency in internal medicine and medical oncology. Prof. Okutur has won a research award and authored numerous papers and book chapters. He is a member of various medical societies.
Dr. Ahmet Belici is an experienced medical oncologist with 20+ years of experience specializing in sarcoma and lung cancer treatments.
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Education and Expertise
Selcuk University Meram Faculty of Medicine - Medical Education
Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization
Experience
Malatya State Hospital Internal Diseases Clinic
Ankara Oncology Hospital Medical Oncology Clinic
Erzurum Regional Training and Research Hospital Medical Oncology Clinic
AREAS OF INTEREST
Lung cancer
esophageal cancer
Gastric cancer
breast cancer
Gastrointestinal surgery
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr
Experience
2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital
2020 - 2021 Yüzüncü Yıl University Faculty of Medicine
2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.
2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department
2018 - 2021 Yüzüncü Yıl University Faculty of Medicine
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant
2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist
2012 - 2015 Suleiman the Magnificent Training and Research Hospital,
2008 - 2012 Haseki Training and Research Hospital
2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.
Education
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2007
Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.
1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990)
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992)
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998)
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.
1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019)
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020)
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)
Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir
Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir
Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5
Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003
Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005
Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008
Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009
Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017
Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017
Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017
11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999. (1.05 points)
Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)
Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003.
Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016
Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017
Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020
National pediatric stem cell transplant activity, 2020
Childhood stem cell transplantation indications, Turkey Clinics - International book 2020
In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.